Detection of Isoniazid and Rifampicin Resistance by Sequencing of katG, inhA, and rpoB Genes in Korea
Open Access
- 1 October 2009
- journal article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 29 (5) , 455-460
- https://doi.org/10.3343/kjlm.2009.29.5.455
Abstract
In Korea, tuberculosis is resistant to isoniazid (INH) and/or rifampicin (RIF) in more than 10% of cases. To prevent the spread of resistant Mycobacterium tuberculosis strains, it is crucial to develop more rapid resistance detection methods. To determine the feasibility of using direct sequencing for detecting INH- and RIF-resistant strains, the katG gene, the regulatory region of the inhA gene, and the 81-bp hot-spot region of the rpoB gene from 95 culture isolates and 46 respiratory specimens were sequenced. Total 141 culture isolates were classified by conventional drug susceptibility testing (DST) as INH(R)/RIF(R) (N=30), INH(R)/RIF(S) (N=23), INH(S)/RIF(R) (N=15), and INH(S)/RIF(S) (N=73). Compared with phenotypic DST, the overall sensitivity and specificity of sequencing were 83.0% (44/53) and 96.6% (85/88), respectively, for INH resistance, and 93.3% (42/45) and 100% (96/96), respectively, for RIF resistance. The rates were similar between culture isolates and respiratory specimens. Interestingly, three specimens with inhA -15C>T mutation were susceptible to INH by conventional DST. Detection of mutations in the katG codon 315, the inhA regulatory region, and the hot-spot region of rpoB would be useful for rapid detection of INH and RIF resistance in Korea.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical SpecimensJournal of Clinical Microbiology, 2007
- Drug Resistance Rates of Mycobacterium tuberculosis at a Private Referral Center in KoreaJournal of Korean Medical Science, 2007
- The Interval Between Initiation of Anti-tuberculosis Treatment in Patients with Culture-positive Pulmonary Tuberculosis and Receipt of Drug-susceptibility Test ResultsJournal of Korean Medical Science, 2007
- Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in ItalyJournal of Clinical Microbiology, 2006
- Comparison of a Conventional Antimicrobial Susceptibility Assay to an Oligonucleotide Chip System for Detection of Drug Resistance in Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2006
- Molecular Analysis of Isoniazid and Rifampin Resistance inMycobacterium tuberculosisIsolates Recovered from BarcelonaMicrobial Drug Resistance, 2005
- Molecular Characterization of Rifampin-Resistant Isolates of Mycobacterium tuberculosis from Hungary by DNA Sequencing and the Line Probe AssayJournal of Clinical Microbiology, 2001
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000
- Characterization of the Catalase-Peroxidase Gene (katG) and inhA Locus in Isoniazid-Resistant and -Susceptible Strains of Mycobacterium tuberculosis by Automated DNA Sequencing: Restricted Array of Mutations Associated with Drug ResistanceThe Journal of Infectious Diseases, 1996
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993